TITLE

Antibacterial and Antiviral Effects of Milk Proteins and Derivatives Thereof

AUTHOR(S)

Floris, Ren�; Recio, Isidra; Berkhout, Ben; Visser, Servaas

PUB. DATE

June 2003

SOURCE

Current Pharmaceutical Design;Jun2003, Vol. 9 Issue 16, p1257

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Milk forms a rich source of biologically interesting components. In particular, its protein fraction is known to encompass many kinds of biological functions. In this review we focus on antibacterial and antiviral properties of milk proteins and milk protein derivatives. The latter include chemically modified proteins and enzymatically induced peptides. If such peptides are released by enzymes present within the digestive tract (e.g. trypsin or pepsin), it is likely that they play a role in the health defense system. This is especially the case when the active fragments can survive the intestinal conditions long enough to arrive at the right place to exert their beneficial function. In the first part of this paper attention is paid to the antibacterial proteins lactoferrin, lactoperoxidase, and lysozyme. Furthermore, antibacterial peptides originating from caseins and whey proteins are described. The second part reports on studies of antiviral effects of milk proteins and derivatives thereof. Special focus is directed to the antiviral action towards the human immunodeficiency virus (HIV) and the human cytomegalovirus (HCMV). Unmodified milk proteins are generally not active against these viruses. An exception is lactoferrin, which shows significant antiviral activity against both HIV and HCMV. Several other milk proteins tested showed strong antiviral effects only after chemical modification, i.e. by making them polyanionic (for anti-HIV activity) or polycationic (for anti-HCMV activity). In a number of cases, conclusions are drawn concerning possible relationships between antibacterial / antiviral activity and molecular structure of the components described.

ACCESSION #

11156568

Tags: MILK proteins;  ANTIBACTERIAL agents

 

Related Articles

• PROPIEDADES DEL PROP�LEO COMO ADITIVO NATURAL FUNCIONAL EN LA NUTRICI�N ANIMAL. Carlos Mu�oz Rodr�guez, Luis; Eduardo Linares Villalba, Sergio; Narv�ez Solarte, William // Biosalud;jul-dic2011, Vol. 10 Issue 2, p101 

  Propolis is a waxy resin of a complex composition and a viscose consistency, that used in animal feeding, favors weight increase and muscle mass gain, by stimulation of food intake. In goats it stimulates production of total solid, fat and milk proteins. It also shows beneficial results in...

• Dirty work. Phillips, Debra // Entrepreneur;May97, Vol. 25 Issue 5, p26 

  Reports on the demand on antibacterial products in the United States according to Susan Small-Weil, consumer behavior psychologist with The Seiden Group, a New York City advertising and consulting firm. Outfitting of children's toys with antibacterial protection; Estimate percentage of...

• Do antigerm products work? Young, Stephanie; Kusek, Kristyn // Glamour;Apr98, Vol. 96 Issue 4, p53 

  Focuses on the need to use antibacterials in the home. Comments made by Stuart Levy, medical doctor and director of the Center for Adaptation Genetics and Drug Resistance at Tufts University School of Medicine in Boston; Impact of antibacterials on weak bacteria; Information on antibacterial...

• An anti-bacterial cloth...  // Consumers' Research Magazine;Apr96, Vol. 79 Issue 4, p41 

  Focuses on antibacterial cloth that contains no chemical. Effectiveness against germs on contact; Features; Contact information.

• A new kind of germ warfare. Friedman, Dorian // U.S. News & World Report;06/02/97, Vol. 122 Issue 21, p10 

  Reports on the multibillion-dollar germ-busting industry in the United States in 1997. Hyperhygienic Americans and microbial soaps and lotions; Consumers purchasing germ-busting products out of fear; Number of people made sick by hand- and airborne bacteria annually; Number of new so-called...

• New weapons against `bugs'. Berardelli, Phil // Insight on the News;12/09/96, Vol. 12 Issue 46, p37 

  Focuses on the development of antibacterial agents to fight new strains of bacteria. Features of scientists' struggle to prevent epidemics; Type of bacteria that are growing new strains resistant to conventional antibiotics; Description of the antibacterial agents being developed.

• Irresistible drugs.  // New Scientist;11/09/96, Vol. 152 Issue 2055, p11 

  Reports on Antimicrobial Research Center's development of treatments to fight multi-drug resistant strains of tuberculosis and malaria focusing on computer-assisted design and monoclonal antibodies.

• Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde. Anderson, Virginia E.; Osheroff, Neil // Current Pharmaceutical Design;Mar2001, Vol. 7 Issue 5, p337 

  Quinolones are a very important family of antibacterial agents that are widely prescribed for the treatment of infections in humans. Although the founding members of this drug class had little clinical impact, successive generations include the most active and broad spectrum oral antibacterials...

• The Chemical and Biological Aspects of Fluoroquinolones Reality and Dreams. Bhanot, S.K.; Singh, M.; Chatterjee, N.R. // Current Pharmaceutical Design;Mar2001, Vol. 7 Issue 5, p311 

  A vast array of fluoroquinolones having excellent broad-spectrum activity form an invaluable part of the present anti-infective armory of the clinicians. A number of these compounds are todays blockbusters of the antibacterial market due to their therapeutic efficacy having tolerable side...

Read the Article